Earnings Call Intelligence Subscribe
Home › Call Sheets › OXY › Q3'25
Call sheet · Q3'25

Occidental Petroleum (OXY)

Q3'25 earnings call · held November 11, 2025 · compared with the Q2'25 call · management-credibility review
10/12
Disclosure score
2 medium, 4 low flags
Financial quality
Bottom line
The sleeper story is that OxyChem proceeds aren't just balance sheet repair - they're funding the commercial rollout of unconventional CO2 EOR that could double recovery rates. Yes, they beat on production and costs again, but the real catalyst is $350M+ annual interest savings enabling mid-cycle EOR investments. The binding constraint remains CO2 availability, not economics or geology, which is why STRATOS timeline matters more than Permian drilling. Hollub's key tell: 'We're not going to aggressively put lots of extra barrels into an oversupplied market' - this is defensive positioning masquerading as discipline. My view changes if they provide specific FID timelines and CO2 supply contracts for the first commercial unconventional EOR projects, or if international production continues disappointing despite Mukhaizna contract improvements.

The 30-second version

  • OxyChem sale proceeds are a stealth gas pedal for Permian unconventional EOR
  • Resource expansion of 2.5B BOE sounds impressive but it's mostly paper gains from modeling
  • Management quietly walking back aggressive positioning on oversupplied oil markets

What changed this quarter

MetricQ2'25Q3'25Change
Total Production (BOE/d)1.4M (Q2)1.47M (Q3)+70k BOE/d beat vs guidance high end
Operating Cash Flow$2.6B (Q2)$3.2B (Q3)+$600M despite $10+ WTI headwind
Free Cash Flow (before WC)$700M (Q2)$1.5B (Q3)+$800M acceleration
Permian Production~770k BOE/d (Q2 implied)800k BOE/d (Q3)Record quarterly Permian production
Domestic LOE per BOE$8.55 (H1 2025)$8.11 (Q3)Lowest since 2021
Total Principal Debt$22.1B (Q2)$20.8B (Q3)-$1.3B in quarter, -$3.6B YTD
Midstream & Marketing Earnings$206M (Q2)$153M (Q3)Still positive, above guidance midpoint
OxyChem Pretax Income~$200M+ (Q2 implied)$197M (Q3)Below guidance, soft chlorovinyl market
Capital Expenditures (Net)~$1.7B quarterly run rate$1.7B (Q3)On track for $300M full-year reduction
Well Costs (Permian)13% reduction YTD vs 202416% reduction since 2022 (Delaware)Continued cost deflation

Accountability tracked

8 new promises made4 narrative shifts flagged6 prior promises scored
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Read the full OXY Q3'25 report Subscribe
About Research ↗Call SheetsCredibility IndexMissed PromisesScreens13F BooksData & InstitutionalPrivacyTermsSubscribe
This is a free preview. The full write-up and promise ledger are published to subscribers on Substack.
Scores, kept-promise rates, and flags on this site reflect the author's opinion, applying a stated methodology to statements management made on public earnings calls. Informational and educational purposes only - not investment advice, a recommendation, or an offer to buy or sell any security. Sources believed reliable but not guaranteed; the author may hold positions in the securities discussed.

Follow what management promises next

Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.

Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.